Last updated: 11/07/2018 17:07:11
The Systemic Pharmacodynamics and Pharmacokinetics of Intranasal Fluticasone Propionate and Intranasal Mometasone Furoate Administered via an Aqueous Nasal Spray in Healthy Subjects
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: The Systemic Pharmacodynamics and Pharmacokinetics of Intranasal Fluticasone Propionate and Intranasal Mometasone Furoate Administered via an Aqueous Nasal Spray in Healthy Subjects
Trial description: The Systemic Pharmacodynamics and Pharmacokinetics of Intranasal Fluticasone Propionate and Intranasal Mometasone Furoate Administered via an Aqueous Nasal Spray in Healthy Subjects
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Daley-Yates PT, Kunka RL, Shen YY, Andrews SM, Callejas S, Ng C. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 60:265-268, 2004
Daley-Yates PT, Kunka RL, Shen YY, Andrews SM, Callejas S, Ng C. The Relative Systemic Exposure to Fluticasone Propionate (FP) and Mometasone Furoate (MF) Administered as Aqueous Nasal Sprays in Healthy Subjects. J Allergy Clin Immunol 2000; 105 (1): S201.
Medical condition
Rhinitis
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
March 1999 to April 1999
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1999-05-04
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website